Get the Stockscreener App
10.99
9.57%
0.96
After Hours:
11.08
0.09
+0.82%
Tempest Therapeutics Inc stock is traded at $10.99, with a volume of 88,277.
It is up +9.57% in the last 24 hours and up +48.71% over the past month.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
See More
Previous Close:
$10.03
Open:
$10.12
24h Volume:
88,277
Relative Volume:
0.68
Market Cap:
$48.80M
Revenue:
-
Net Income/Loss:
$-43.10M
P/E Ratio:
-1.1365
EPS:
-9.67
Net Cash Flow:
$-36.82M
1W Performance:
+10.79%
1M Performance:
+48.71%
6M Performance:
+3.72%
1Y Performance:
-32.37%
1-Day Range:
$10.12
$11.17
1-Week Range:
$9.50
$11.17
52-Week Range:
$5.3495
$20.67
Tempest Therapeutics Inc Stock (TPST) Company Profile
Name
Tempest Therapeutics Inc
Sector
Industry
Phone
415-798-8589
Address
2000 SIERRA POINT PARKWAY, BRISBANE
Compare TPST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
10.99 | 44.53M | 0 | -43.10M | -36.82M | -9.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Apr-10-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Feb-08-24 | Initiated | Jefferies | Buy |
Tempest Therapeutics Inc Stock (TPST) Latest News
Backtesting results for Tempest Therapeutics Inc. trading strategiesEarnings Overview Summary & Community Verified Swing Trade Signals - Newser
Custom strategy builders for tracking Tempest Therapeutics Inc.Portfolio Update Summary & Stepwise Swing Trade Plans - Newser
Is Tempest Therapeutics Inc. forming a reversal patternWeekly Stock Summary & Smart Money Movement Alerts - Newser
How Tempest Therapeutics Inc. stock performs during market volatilityJuly 2025 Sentiment & Accurate Technical Buy Alerts - Newser
Published on: 2025-09-06 00:39:49 - خودرو بانک
What are Tempest Therapeutics Inc.’s recent SEC filings showingEarnings Trend Report & Low Risk High Reward Ideas - خودرو بانک
Is Tempest Therapeutics Inc. stock a good pick for beginnersCPI Data & Weekly High Momentum Picks - خودرو بانک
Using AI based signals to follow Tempest Therapeutics Inc.Short Setup & Verified Swing Trading Watchlists - Newser
Risk vs reward if holding onto Tempest Therapeutics Inc.Market Weekly Review & Verified Swing Trading Watchlist - Newser
Chart based exit strategy for Tempest Therapeutics Inc.2025 Retail Activity & Low Risk Entry Point Tips - Newser
What technical models suggest about Tempest Therapeutics Inc.’s comebackMarket Activity Recap & Technical Analysis for Trade Confirmation - Newser
Market reaction to Tempest Therapeutics Inc.’s recent newsTake Profit & Real-Time Chart Breakout Alerts - Newser
Technical analysis overview for Tempest Therapeutics Inc. stockPortfolio Value Report & Long-Term Investment Growth Plans - Newser
What data driven models say about Tempest Therapeutics Inc.’s futureTrade Volume Report & Real-Time Stock Price Movement Reports - Newser
Quantitative breakdown of Tempest Therapeutics Inc. recent move2025 Market Outlook & Fast Momentum Stock Entry Tips - Newser
Will Tempest Therapeutics Inc. outperform the market2025 Trading Volume Trends & Fast Moving Market Watchlists - Newser
Long term hold vs stop loss in Tempest Therapeutics Inc.2025 AllTime Highs & Daily Volume Surge Trade Alerts - Newser
How to interpret RSI for Tempest Therapeutics Inc. stockMarket Performance Summary & AI Powered Market Entry Ideas - Newser
Using economic indicators to assess Tempest Therapeutics Inc. potentialPrice Action & Low Drawdown Momentum Ideas - Newser
Is Tempest Therapeutics Inc. a candidate for recovery play2025 Buyback Activity & Reliable Momentum Entry Alerts - Newser
Using data tools to time your Tempest Therapeutics Inc. exitGDP Growth & Weekly Market Pulse Updates - Newser
Forecasting Tempest Therapeutics Inc. price range with options data2025 Major Catalysts & Weekly High Return Opportunities - Newser
What is Tempest Therapeutics Inc.’s valuation compared to sectorJuly 2025 Highlights & Long-Term Capital Growth Strategies - khodrobank.com
How to read the order book for Tempest Therapeutics Inc.2025 Trade Ideas & AI Powered Market Entry Strategies - Newser
Analyzing Tempest Therapeutics Inc. with multi timeframe charts2025 Key Lessons & Free Accurate Trade Setup Notifications - Newser
Is Tempest Therapeutics Inc. a turnaround storyPortfolio Gains Report & Short-Term Trading Opportunity Alerts - خودرو بانک
Tempest Therapeutics Inc. stock chart pattern explainedWeekly Trade Analysis & Consistent Profit Trade Alerts - Newser
Order flow analysis tools used on Tempest Therapeutics Inc.2025 Performance Recap & Real-Time Buy Signal Alerts - Newser
Custom watchlist performance reports with Tempest Therapeutics Inc.2025 Pullback Review & Free Weekly Chart Analysis and Trade Guides - Newser
What is Tempest Therapeutics Inc. s P E ratio telling us2025 Volume Leaders & Momentum Based Trading Ideas - خودرو بانک
Leading vs lagging indicators on Tempest Therapeutics Inc. performanceQuarterly Trade Summary & Weekly Chart Analysis and Trade Guides - Newser
What institutional flow reveals about Tempest Therapeutics Inc.Weekly Trade Report & Detailed Earnings Play Strategies - Newser
Is Tempest Therapeutics Inc. a play on infrastructure spendingTrend Reversal & Low Drawdown Momentum Ideas - خودرو بانک
How to build a dashboard for Tempest Therapeutics Inc. stockEarnings Recap Summary & Daily Stock Momentum Reports - Newser
Comparing Tempest Therapeutics Inc. in custom built stock radarsProduct Launch & Short-Term Trading Opportunity Alerts - Newser
Best data tools to analyze Tempest Therapeutics Inc. stockMarket Movers & Verified Technical Signals - Newser
Tempest Therapeutics Inc. stock outlook for YEAREarnings Trend Report & Daily Technical Stock Forecast Reports - Newser
Is Tempest Therapeutics Inc. stock bottoming out2025 Volatility Report & AI Driven Stock Movement Reports - Newser
Tempest Therapeutics Inc Stock (TPST) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):